Ilse Treurnicht
Director/Board Member chez ZENTEK LTD.
Fortune : 1 803 $ au 31/03/2024
Profil
Ilse Treurnicht is currently the Chairman at Public Policy Forum and Triphase Accelerator Corp.
She is also an Independent Director at Zentek Ltd.
and a Director at MaRS Discovery District and Zentek Solutions Ltd.
In the past, she served as the President & Chief Executive Officer at Primaxis Technology Ventures, Inc. and as the Chief Executive Officer at MaRS Discovery District (Venture Capital) from 2005 to 2017.
She has also held positions as a Director at Toronto Venture Group and Toronto Innovation Acceleration Partners.
Dr. Treurnicht holds a doctorate degree from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZENTEK LTD.
0,00% | 08/12/2023 | 1 500 ( 0,00% ) | 1 803 $ | 31/03/2024 |
Postes actifs de Ilse Treurnicht
| Sociétés | Poste | Début |
|---|---|---|
| ZENTEK LTD. | Director/Board Member | 05/07/2022 |
MaRS Discovery District
 MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Director/Board Member | 13/02/2013 |
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Chairman | - |
Zentek Solutions Ltd.
 Zentek Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Zentek part of the Tribune Group are dedicated to delivering the best educational technology, enhancing teaching and learning. They believe that being the part of Tribune, it will create a larger, more robust and capable organization with a prime focus on addressing education sector ICT requirements for existing and new customers. The resultant Tribune organization will have a broader geographic coverage, increased staff numbers and improved skills in all aspects of the business; they will be even better placed to serve the customer in the future. With their wealth of experience and dedication to finding the best possible educational solutions, they offer an unrivalled range of products and services to meet customer specific requirements: PC's and Laptops Servers Networking systems Wired and wireless connectivity software Managed services They ensure quality, consistency and e-safety, that creates a stable foundation for learning outcomes and ensures customer to get the most from ICT for education. | Director/Board Member | 05/07/2022 |
| Public Policy Forum | Chairman | - |
Anciens postes connus de Ilse Treurnicht
| Sociétés | Poste | Fin |
|---|---|---|
MaRS Discovery District (Venture Capital)
 MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Chief Executive Officer | 01/10/2017 |
Toronto Venture Group
 Toronto Venture Group Investment ManagersFinance Toronto Venture Group provides advisory, finance and management services. It bridges the gap between entrepreneurs and capital through education, communication and networking events. It provides investment ready-entrepreneurs with presentation opportunities to qualified investors. It was founded in 1990 and is headquartered in Toronto, Canada. | Director/Board Member | 14/10/2008 |
Primaxis Technology Ventures, Inc.
 Primaxis Technology Ventures, Inc. Investment ManagersFinance Primaxis Technology Ventures, Inc. operated as a venture capital firm. The company was founded in 1999 and was headquartered in Toronto, Canada. | President | - |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Director/Board Member | - |
Formation de Ilse Treurnicht
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZENTEK LTD. | Non-Energy Minerals |
| Entreprise privées | 8 |
|---|---|
Primaxis Technology Ventures, Inc.
Primaxis Technology Ventures, Inc. Investment ManagersFinance Primaxis Technology Ventures, Inc. operated as a venture capital firm. The company was founded in 1999 and was headquartered in Toronto, Canada. | Finance |
Toronto Venture Group
Toronto Venture Group Investment ManagersFinance Toronto Venture Group provides advisory, finance and management services. It bridges the gap between entrepreneurs and capital through education, communication and networking events. It provides investment ready-entrepreneurs with presentation opportunities to qualified investors. It was founded in 1990 and is headquartered in Toronto, Canada. | Finance |
| Public Policy Forum | |
MaRS Discovery District
MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Commercial Services |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Health Technology |
Zentek Solutions Ltd.
Zentek Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Zentek part of the Tribune Group are dedicated to delivering the best educational technology, enhancing teaching and learning. They believe that being the part of Tribune, it will create a larger, more robust and capable organization with a prime focus on addressing education sector ICT requirements for existing and new customers. The resultant Tribune organization will have a broader geographic coverage, increased staff numbers and improved skills in all aspects of the business; they will be even better placed to serve the customer in the future. With their wealth of experience and dedication to finding the best possible educational solutions, they offer an unrivalled range of products and services to meet customer specific requirements: PC's and Laptops Servers Networking systems Wired and wireless connectivity software Managed services They ensure quality, consistency and e-safety, that creates a stable foundation for learning outcomes and ensures customer to get the most from ICT for education. | Commercial Services |
MaRS Discovery District (Venture Capital)
MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Finance |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Health Technology |
